Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in type 2 diabetes
NCT00154401Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2005
- Primary completion
- Oct 2005
- Modality
- Peptides
- Countries
- 4
01
Overview
A Phase 2 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jan 2005; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00154401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154401.